The leaders in the business of weight-loss drugs, Novo Nordisk and Eli Lilly, are fighting on a number of fronts to get Medicare officials to pay for the popular medicines.
ResMed stock and Inspire Medical Systems stock tumbled Monday after Eli Lilly said its weight-loss drug reduced sleep apnea events.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.